基于电子健康记录的提示干预与老年乳腺癌腋窝手术:非随机对照试验
该非随机对照试验在8家门诊评估嵌入电子健康记录(EHR)的提示干预对符合Choosing Wisely标准的老年早期乳腺癌患者前哨淋巴结活检(SLNB)率的影响。干预后SLNB率从46.9%降至23.8%,中断时间序列模型显示调整后OR为0.26(95%CI 0.07-0.90;提示干预可显著减少低价值腋窝手术。
要点
- EHR提示干预使符合Choosing Wisely标准的老年乳腺癌患者SLNB率降低23.1个百分点。
- 调整后分析显示干预与SLNB率降低独立相关(OR 0.26,95%CI 0.07-0.90)。
- 外科医生对干预的可接受性、适宜性和可行性评分高。
核心结论
- 基于EHR的提示干预显著降低了老年早期cN0 HR+/HER2-乳腺癌患者的低价值腋窝手术率。
研究设计与样本
- 非随机对照试验(混合1型效果-实施研究),纳入8家门诊的7名乳腺外科肿瘤医生,收集符合Choosing Wisely标准的女性患者数据。
- 研究包括12个月干预前对照期和12个月干预期,后续进行半结构化访谈。
主要发现
- 对照期(n=194)与干预期(n=193)患者基线特征相似,中位年龄均为75岁(IQR 72-79)。
- 未调整SLNB率从干预前的46.9%降至干预后的23.8%,下降23.1个百分点(95%CI -32.9至-13.8)。
- 外科医生对干预的可接受性、适宜性和可行性评分高;访谈主题表明提示有助于提醒适用性且无需额外点击。
关键数值与推荐
- Choosing Wisely推荐:对年龄≥70岁、cT1-T2、cN0、HR+/HER2-早期乳腺癌女性,避免常规腋窝分期。
临床怎么用
- 可将EHR提示嵌入外科医生日程,自动标识符合Choosing Wisely标准的患者,以促进SLNB省略决策。
- 该干预用户友好且易于实施,可能适用于其他实践场景或患者人群以减少低价值医疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Choosing Wisely recommendations advocate against routine use of axillary staging in older women with early-stage, clinically node-negative (cN0), hormone receptor-positive (HR+), and HER2-negative breast cancer. However, rates of sentinel lymph node biopsy (SLNB) in this population remain persistently high. OBJECTIVE: To evaluate whether an electronic health record (EHR)-based nudge intervention targeting surgeons in their first outpatient visit with patients meeting Choosing Wisely criteria decreases rates of SLNB. DESIGN, SETTING, AND PARTICIPANTS: This nonrandomized controlled trial was a hybrid type 1 effectiveness-implementation study with subsequent postintervention semistructured interviews and lasted from October 2021 to October 2023. Data came from EHRs at 8 outpatient clinics within an integrated health care system; participants included 7 breast surgical oncologists. Data were collected for female patients meeting Choosing Wisely criteria for omission of SLNB (aged ≥70 years with cT1 and cT2, cN0, HR+/HER2- breast cancer). The study included a 12-month preintervention control period; baseline surveys assessing perceived acceptability, appropriateness, and feasibility of the designed intervention; and a 12-month intervention period. INTERVENTION: A column nudge was embedded into the surgeon's schedule in the EHR identifying patients meeting Choosing Wisely criteria for potential SLNB omission. MAIN OUTCOMES AND MEASURES: The primary outcome was rate of SLNB following nudge deployment into the EHR. RESULTS: Similar baseline demographic and tumor characteristics were observed before (control period, n = 194) and after (intervention period, n = 193) nudge deployment. Patients in both the control and intervention period had a median (IQR) age of 75 (72-79) years. Compared with the control period, unadjusted rates of SLNB decreased by 23.1 percentage points (46.9% SLNB rate prenudge to 23.8% after; 95% CI, -32.9 to -13.8) in the intervention period. An interrupted time series model showed a reduction in the rate of SLNB following nudge deployment (adjusted odds ratio, 0.26; 95% CI, 0.07 to 0.90; P = .03). The participating surgeons scored the intervention highly on acceptability, appropriateness, and feasibility. Dominant themes from semistructured interviews indicated that the intervention helped remind the surgeons of potential Choosing Wisely applicability without the need for additional clicks or actions on the day of the patient visit, which facilitated use. CONCLUSIONS AND RELEVANCE: This study showed that a nudge intervention in the EHR significantly decreased low-value axillary surgery in older women with early-stage, cN0, HR+/HER2- breast cancer. This user-friendly and easily implementable EHR-based intervention could be a beneficial approach for decreasing low-value care in other practice settings or patient populations. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06006910.
引用
- Carleton N, Radomski TR, Li D, et al. Electronic Health Record-Based Nudge Intervention and Axillary Surgery in Older Women With Breast Cancer: A Nonrandomized Controlled Trial. JAMA Surg. 2024. PMID: 39018053. doi:10.1001/jamasurg.2024.2407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。